Krystal Biotech, Inc. KRYS Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s change in AP?
- Krystal Biotech, Inc. (KRYS) reported change in AP of $1.02M in Q1 2026.
- How has Krystal Biotech, Inc.'s change in AP changed year-over-year?
- Krystal Biotech, Inc.'s change in AP increased by 12.8% year-over-year, from $906K to $1.02M.
- What is the long-term trend for Krystal Biotech, Inc.'s change in AP?
- Over 2 years (2021 to 2023), Krystal Biotech, Inc.'s change in AP has grown at a -62.3% compound annual growth rate (CAGR), from $712K to -$101K.
- What does change in AP mean?
- The change in the amount the company owes to its suppliers.
- How do you interpret change in AP?
- An increase indicates the company is delaying cash outflows to preserve liquidity, while a decrease indicates faster payment to vendors.
- How does change in AP compare across companies?
- A standard metric for evaluating short-term liquidity and vendor relationship management across all sectors.